Trials / Completed
CompletedNCT03491722
Surviving a Decade or More After Coronary Revascularization in a Middle Eastern Population
Evolution of Risk Factors and Revascularization Among >1 Decade Survivors After Coronary Revascularization in the Middle East
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,000 (actual)
- Sponsor
- Jordan Collaborating Cardiology Group · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
The study will look at the cardiovascular risk factors as they arise, as well at the need for further revascularization after at least 10 years of coronary revascularization in Middle Eastern patients. The PI will overlook the whole process. Dr Ahmad Tamari, the assistant to the PI will asses this whole process of data collection, management and manuscript drafting.
Detailed description
Middle Eastern patients aged 18 years or above presenting to cardiology service at one tertiary care center who had coronary revascularization (stent or coronary bypass surgery, i.e., index procedure) at least 10 years back, will interviewed to determine: 1. Evolution of cardiovascular risk factors in the period from index procedure to time of interview. These risk factors include; hypertension, diabetes, smoking, dyslipidemia and obesity. 2. Need for further arterial revascularization from the index procedure to time of interview. These arterial revascularization procedures include A. Coronary: stent and/or bypass surgery B. Carotid endarterectomy. C. peripheral arterial revascularization D. Renal artery stent. 3. Medications used at the time if interview with special emphases on the guideline-recommended medications including antiplatelet agents, beta blockers, statins and renin angiotensin blockers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | risk factors and revascularization procedures | arterial revascularizations needed since index procedure |
Timeline
- Start date
- 2018-06-01
- Primary completion
- 2019-06-10
- Completion
- 2019-06-10
- First posted
- 2018-04-09
- Last updated
- 2023-05-25
Locations
2 sites across 1 country: Jordan
Source: ClinicalTrials.gov record NCT03491722. Inclusion in this directory is not an endorsement.